Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

Also called NCT01350310

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01350310
Other papers using this trial's data
  • Intracoronary transplantation of CD34(+) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy Journal of cardiac failure, 2015-02 DOI, PubMed 25459687

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Slovenia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01350310. Randomized; single masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2014-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy
Acronym
NOGA-DCM
Condition
Dilated Cardiomyopathy
Condition
Chronic Heart Failure
Intervention (Procedure)
Intramyocardial injection
Intervention (Procedure)
Intracoronary injection
Intervention (Procedure)
Intramyocardial injection
Lead sponsor
University Medical Centre Ljubljana (class: other)
Collaborator
The Methodist Hospital Research Institute (class: other)
Collaborator
Stanford University (class: other)

Record details

Record id
cardio:ct-nct01350310
Content hash
d569e4f5aa228e66d2502b49eaceda50789219e4b4a3ac09749bbdb4b92a3fe1